Compliance updated on Jun 19, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

Marvel Biosciences Corp

MRVL.V ✓ COMPLIANT ☆ Track — members

TSX Venture · Healthcare · Biotechnology & Medical Research ·

Canada Micro Cap Analyst: N/A

Last Close

$0.12

▲ +6.25%

Market Cap $7.71M · Vol 62.50K

Key Metrics

P/E Ratio

N/A

FWD: N/A

Market Cap

$7.71M

Micro Cap

Div Yield

N/A

EPS Growth

N/A

YoY

RSI (14)

55.56

Momentum

Beta

0.63

vs Market

52W High

$0.29

57.89% below

52W Low

$0.08

44.82% above

Volume

62.50K

Avg 62.01K

P/B

N/A

Price-to-book

ROE

N/A

Return on equity

Free Float

70.19%

Public shares

Shariah Compliance8 STANDARDS

✓ Yes, Marvel Biosciences Corp (MRVL.V) stock is Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See the verdict under each standard, the exact screening ratios, purification and zakat per share. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does MRVL.V pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

+3.03%

+9.68%

+13.33%

YTD

+25.93%

-10.53%

+120.54%

-29.17%

Financials & Valuation

TTM · Annual

Total Revenue	$0.00
Net Income	$-1,596,499.00
Revenue Growth (YoY)	N/A
Gross Margin	N/A
Operating Margin	N/A
Net Profit Margin	N/A
ROE	N/A
ROA · ROIC	-540.68% · N/A

P/E Ratio	N/A
Forward P/E (FY1)	N/A
PEG Ratio	N/A
P/S	N/A
P/B	N/A
P/FCF	N/A
EPS Growth	N/A
Outstanding Shares	63.14M

Technical Indicators

50-Day SMA	$0.12
200-Day SMA	$0.11
RSI (14)	55.56
Beta	0.63
52-Week High	$0.29
52-Week Low	$0.08

Volume Today	62.50K
Avg Daily Volume (30D)	62.01K
Relative Volume	1.01x
Volatility (10D)	103.36
Volatility (30D)	84.82
Free Float	70.19%

Analyst Consensus

N/A

Current Price $0.12

Mean Target N/A

52W Low$0.08 52W High$0.29

Current

Target

$0.08 $0.29

Current Analyst target

· 0 analysts

Identifiers

ExchangeTSX Venture

FIGIBBG00MXMTCB6

ISINCA57384M1077

CountryCanada

Sub-IndustryBiotechnology & Medical Research (NEC)

Earnings DateN/A

TypeStocks

Instrument TypeORD Ordinary Share

Similar Halal Stocks

LONN.S Lonza Group AG -1.78% RVMD Revolution Medicines Inc +0.85% ONC BeOne Medicines AG -2.40% 068270.KS Celltrion Inc -0.50% ABVX Abivax SA -2.05%

Company Profile

Marvel Biosciences Corp. is a Canada-based pre-clinical-stage pharmaceutical development biotechnology company. The Company develops new synthetic chemical derivatives of the original approved drug for the new disease indication. It has developed several new chemical entities, using synthetic chemical derivatives of known, off-patent drugs that inhibit the A2a adenosine receptor with application to neurological diseases (depression and anxiety, Alzheimer's, attention deficit hyperactivity disorder (ADHD)), and the non-neurological conditions of cancer and non-alcoholic steatohepatitis. The Company's lead compound, MB-204, is a fluorinated derivative of Istradefylline. The Company is engaged in developing MB-204 for diseases other than Parkinson's disease, specifically depression, Alzheimer’s Disease and liver fibrosis due to non-alcoholic steatohepatitis (NASH). Its wholly owned subsidiary is Marvel Biotechnology Inc.